Industrials and Chemicals

On June 29, 2026, Martin Marietta Materials, Inc. (“Martin Marietta”), a leading supplier of aggregates and other building materials, announced that it has entered into a definitive agreement to combine with Lhoist North America, Inc. (“Lhoist North America”), a leading producer of hi‑calcium lime, dolomitic lime and industrial mineral products and a subsidiary of Lhoist Group, for $13.5 billion in cash and shares of Martin Marietta common stock. The transaction is expected to be completed in the second half of 2026, subject to regulatory approvals. Cravath is representing Martin Marietta in connection with the transaction.

On June 23, 2026, Westinghouse Electric Corporation (“Westinghouse”) announced its intention to partner with the U.S. Department of Energy (“DOE”) Office of Energy Dominance Financing (“EDF”) under the American Nuclear Supply Chain Loans program. The program will enable investment in nuclear supply chains and accelerate deployment of new nuclear generation at scale in the United States. EDF has announced a conditional commitment (subject to Westinghouse, its owners and its partners satisfying certain conditions) of $17.5 billion in obligated funds to finance the purchase of long‑lead time items (“LLI”) for up to 10 Westinghouse AP1000® units, the only fully designed and licensed advanced commercial reactor operating in the United States today. Westinghouse will partner with up to five eligible utilities or energy companies to procure LLI for projects with two reactors each and has signed letters of intent with seven potential partners with identified sites. Cravath is representing Westinghouse in connection with the transaction.

On June 16, 2026, Olin Corporation and Huntsman Corporation announced that they have entered into a definitive agreement to combine in an all-stock merger of equals to create a $12+ billion North American chemicals leader. Under the terms of the agreement, Huntsman shareholders will receive 0.5476 shares in Olin for every one share of Huntsman. Upon completion of the transaction, Olin shareholders will own approximately 54.5% and Huntsman shareholders will own approximately 45.5% of the combined company, which will be renamed OlinHuntsman Corporation. Upon closing of the transaction, current Olin President and Chief Executive Officer, Ken Lane, will serve as Chief Executive Officer of OlinHuntsman. Current Chairman, President and Chief Executive Officer of Huntsman, Peter Huntsman, will serve as non-executive Chairman of OlinHuntsman’s Board of Directors. OlinHuntsman’s Board of Directors will consist of ten members, with equal representation from Olin and Huntsman. The transaction is expected to close in the first half of 2027, subject to the satisfaction of customary closing conditions, including receipt of required regulatory approvals and the approval of Olin’s shareholders and Huntsman’s shareholders. Cravath is representing Olin Corporation in connection with the transaction.

Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $1.35 billion of credit facilities made available to subsidiaries of Versigent Limited, a global leader in the design, development and manufacture of low voltage and high voltage electrical architectures and the holding company for Aptiv PLC’s Electrical Distribution Systems segment, which Aptiv PLC spun off into a separate, independent, publicly traded company. The proceeds were used to partially finance the spin‑off. The credit facilities consisted of a $500 million term loan facility and an $850 million revolving credit facility. The transaction closed on November 26, 2025.

Cravath represented the initial purchasers in connection with the $700 million 144A/Reg. S high‑yield senior notes offering of The Chemours Company a leading, global provider of performance chemicals. The transaction closed on March 12, 2026.

On December 9, 2025, Cravath was recognized by the Financial Times in connection with its annual “North America Innovative Lawyers” report, which showcases “the most innovative work and legal services that lawyers have developed for clients in North America.” The Firm received “Highly commended” honors in the “Dealmaking” category for its representation of Vista Outdoor in its $1.125 billion sale of Revelyst to SVP and $2.225 billion sale of The Kinetic Group to CSG.

On November 28, 2025, Cravath’s antitrust practice was ranked among the “Elite” in Global Competition Review’s 2026 edition of GCR 100, a guide to the world’s best competition practices. This is the fourteenth consecutive year the Firm has been ranked in the highest tier among New York Firms by GCR. The publication highlighted Cravath as a “premier choice for major antitrust litigation, enforcement actions and high‑profile transactional matters,” noting its representations of clients including Corteva in antitrust litigation brought by the FTC and related putative class actions; Elsevier in putative class action antitrust litigation; Epic Systems in an action filed by Particle Health; and Wiz on antitrust matters in connection with its $32 billion acquisition by Google.

In an article highlighting the October release of the 2025 edition of IFLR1000, IFLR named Cravath among the law firms that “made the largest strides in the banking and finance rankings across four key European markets this year.” It further pointed to Cravath’s “sharp ascent” in rankings as evidence of U.S. firms becoming increasingly active in London’s finance space. The 2025 edition of IFLR1000 recognized Cravath across five categories: Bank Lending – Lender Side, Bank Lending – Sponsor Side, Capital Markets – Debt, Capital Markets – Equity and Capital Markets – High Yield.

On September 18, 2025, the Financial Times recognized Cravath at the publication’s Innovative Lawyer Europe Awards 2025, which recognize the most innovative work and legal service lawyers have developed for their clients in Europe. Cravath was chosen as the winner in the “Dealmaking” category in recognition of the Firm’s representation of the lead arrangers and initial purchasers in the €1.9 billion financing supporting TDR Capital and I Squared Capital’s public-to-private acquisition of Applus+.

On August 11, 2025, Cravath published the latest edition of its Quarterly Review, which provides insight into practical points, key takeaways and relevant developments across the M&A, activism, tax, regulatory and corporate governance landscape. This edition covers: